ES2116600T3 - Metodos y composiciones para mejorar el contraste de imagenes. - Google Patents

Metodos y composiciones para mejorar el contraste de imagenes.

Info

Publication number
ES2116600T3
ES2116600T3 ES94920543T ES94920543T ES2116600T3 ES 2116600 T3 ES2116600 T3 ES 2116600T3 ES 94920543 T ES94920543 T ES 94920543T ES 94920543 T ES94920543 T ES 94920543T ES 2116600 T3 ES2116600 T3 ES 2116600T3
Authority
ES
Spain
Prior art keywords
contrast
images
compositions
improve
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94920543T
Other languages
English (en)
Inventor
Anders Ericcson
Anne Kjersti Fahlvik
Anders Hemmingsson
Mats Wikstrom
Audun Oksendal
Tore Bach-Gansmo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of ES2116600T3 publication Critical patent/ES2116600T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Signal Processing (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Semiconductor Lasers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ESTA INVENCION SE REFIERE A MEJORAS EN O RELATIVAS A LA FORMACION DE IMAGENES POR RESONANCIA MAGNETICA DE UN CUERPO HUMANO O NO HUMANO, EN PARTICULAR A UN METODO EN QUE SE AÑADEN AGENTES DE CONTRASTE POSITIVOS Y NEGATIVOS PARA AUMENTAR EL CONTRASTE DE LA IMAGEN.
ES94920543T 1993-07-12 1994-07-11 Metodos y composiciones para mejorar el contraste de imagenes. Expired - Lifetime ES2116600T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939314499A GB9314499D0 (en) 1993-07-12 1993-07-12 Method

Publications (1)

Publication Number Publication Date
ES2116600T3 true ES2116600T3 (es) 1998-07-16

Family

ID=10738767

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94920543T Expired - Lifetime ES2116600T3 (es) 1993-07-12 1994-07-11 Metodos y composiciones para mejorar el contraste de imagenes.

Country Status (14)

Country Link
US (2) US5869023A (es)
EP (1) EP0708927B1 (es)
JP (1) JPH09502426A (es)
CN (1) CN1127040A (es)
AT (1) ATE166464T1 (es)
AU (1) AU7129594A (es)
CA (1) CA2165086A1 (es)
DE (1) DE69410466T2 (es)
ES (1) ES2116600T3 (es)
GB (1) GB9314499D0 (es)
NO (1) NO960120L (es)
NZ (1) NZ268397A (es)
WO (1) WO1995002831A1 (es)
ZA (1) ZA945038B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
GB9809776D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
SE9803718D0 (sv) 1998-05-26 1998-10-28 Klaus Potthoff Diagnostiseringsmedel
EP1105162A1 (en) * 1998-08-10 2001-06-13 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
CZ2002343A3 (cs) * 1999-07-29 2002-08-14 Epix Medical, Inc. Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
US6804546B1 (en) * 2001-04-20 2004-10-12 Koninklijke Philips Electronics, N.V. Multiple contrast echo-planar imaging for contrast-enhanced imaging
US6723052B2 (en) * 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
NO20020780D0 (no) * 2002-02-15 2002-02-15 Amersham Health As Bildeanalyse
US7713517B2 (en) * 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
DE602005009173D1 (de) * 2004-05-03 2008-10-02 Koninkl Philips Electronics Nv System und verfahren zur magnetresonanzabbildung
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
US20060020152A1 (en) * 2004-07-22 2006-01-26 Theobald Eugene H Method for the low temperature selective oxidation of hydrogen contained in a hydrocarbon stream
NO20043746L (no) * 2004-09-07 2006-03-08 Heidi Brurok MRI-metode for a vurdere myokardisk funksjon, levedyktighet og perfusjon i ischemisk hjertesykdom
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
EP1891455A2 (en) * 2005-06-01 2008-02-27 Philips Intellectual Property & Standards GmbH Determination of distribution information of a contrast agent by mr molecular imaging
JP5242672B2 (ja) * 2007-04-11 2013-07-24 オレゴン ヘルス アンド サイエンス ユニバーシティ 心臓における線維症の非侵襲性の定量的検出のためのシステム
EP2192922A4 (en) 2007-09-17 2010-09-29 Univ California INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGING PROSTATE <I> IN SITU CANCER CELLS </ I>
CN104274840A (zh) * 2007-12-05 2015-01-14 马维尔生物科学公司 纳米级对比剂和使用方法
AU2009257279A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
EP2332122A4 (en) 2008-10-02 2013-11-20 Univ Western Ontario SYSTEM AND METHOD FOR IMAGE PROCESSING
EP2684048B1 (en) 2011-03-11 2018-10-03 Board of Regents of the University of Nebraska Biomarker for coronary artery disease
CA3006759A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method
MX2023001625A (es) 2020-08-07 2023-05-16 Fortis Therapeutics Inc Inmunoconjugados que se dirigen a cd46 y metodos de uso de los mismos.
US11630219B2 (en) * 2021-07-29 2023-04-18 Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C Pressure-regulating large-area windowless airflow proportional counter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region

Also Published As

Publication number Publication date
US5869023A (en) 1999-02-09
DE69410466D1 (de) 1998-06-25
NO960120L (no) 1996-03-11
WO1995002831A1 (en) 1995-01-26
CN1127040A (zh) 1996-07-17
ATE166464T1 (de) 1998-06-15
EP0708927A1 (en) 1996-05-01
US6045775A (en) 2000-04-04
NZ268397A (en) 1997-11-24
AU7129594A (en) 1995-02-13
DE69410466T2 (de) 1999-02-18
CA2165086A1 (en) 1995-01-26
EP0708927B1 (en) 1998-05-20
JPH09502426A (ja) 1997-03-11
NO960120D0 (no) 1996-01-11
GB9314499D0 (en) 1993-08-25
ZA945038B (en) 1995-03-27

Similar Documents

Publication Publication Date Title
ES2116600T3 (es) Metodos y composiciones para mejorar el contraste de imagenes.
MX9306625A (es) Particulas de manganeso en agua como agentes de realce de contraste por resonancia magnetica.
IT1256248B (it) Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
CR6530A (es) Metodo para inhibir la agregacion de proteinas amiloidesy formacion de imagenes de depositos amiloides utilizando derivados de isoindolina
PT907379E (pt) Agentes de contraste bioactivados para imagiologia de diagnostico
BR9607012A (pt) Processo para gerar uma imagem de corpo de animal humano por formação de imagem luminosa uso de uma material em partículas fisiologicamente toleráveis e composição de formação de imagem diagnóstica
DE69519752T2 (de) Freie heterocyclische Methylradikale als Bildverbesserungsmittel
BR9914940A (pt) Método para aperfeiçoar a farmacocinética de tipranavir
DE69325184D1 (de) Verfahren zur verbesserung der fettsättigung während der bilderzeugung mittels magnetischer resonanz
CR6528A (es) Metodo para inhibir la agregcion de proteinas amiloidesy formacion de imagenes de depositos amiloides
SE9600779L (sv) Anordning för visuell storleksmätning
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
BR9406199A (pt) Agente de contraste uso do mesmo suspensões e concentrados não-aquosos formas formuladas a partir de um agente de contraste e processos para a preparação de um agente de contraste e para geração de imagens melhoradas de um corpo de animal humano ou não-humano
NO984555L (no) T1- Lever
GR3020861T3 (en) Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
ZA961485B (en) Liposome suspensions as blood pool imaging contrast agents
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
IL100225A0 (en) Control of parasitic worms
EP0948361A4 (en) MAGNETIC RESONANCE BLOOD POOL IMAGING AGENTS
MX9203516A (es) Neue antikoagulatorisch wirksame peptide.
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
NO961524D0 (no) Sfæriske komplekser som relakseringsmidler for forbedring av bilde i magnetisk resonansavbilding
TH14302S (th) ชุดอุปกรณ์ทำให้เกิดภาพสำหรับการสร้างภาพ
CA2060536A1 (en) Specific contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708927

Country of ref document: ES